Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 18 entries
Sorted by: Best Match Show Resources per page
Tumor Banks: A Quality Control Scheme Proposal.

Frontiers in medicine

Craciun L, Spinette SA, Rassy M, Salgado R, de Wind A, Demetter P, Verset L, Gomez-Galdon M, Chintinne M, Sirtaine N, de St Aubain N, Laios I, Roy F, Larsimont D.
PMID: 31681781
Front Med (Lausanne). 2019 Oct 17;6:225. doi: 10.3389/fmed.2019.00225. eCollection 2019.

No abstract available.

Cite
Craciun L, Spinette SA, Rassy M, et al. Tumor Banks: A Quality Control Scheme Proposal. Front Med (Lausanne). 2019;6:225doi: 10.3389/fmed.2019.00225.
Craciun, L., Spinette, S. A., Rassy, M., Salgado, R., de Wind, A., Demetter, P., Verset, L., Gomez-Galdon, M., Chintinne, M., Sirtaine, N., de St Aubain, N., Laios, I., Roy, F., & Larsimont, D. (2019). Tumor Banks: A Quality Control Scheme Proposal. Frontiers in medicine, 6225. https://doi.org/10.3389/fmed.2019.00225
Craciun, Ligia, et al. "Tumor Banks: A Quality Control Scheme Proposal." Frontiers in medicine vol. 6 (2019): 225. doi: https://doi.org/10.3389/fmed.2019.00225
Craciun L, Spinette SA, Rassy M, Salgado R, de Wind A, Demetter P, Verset L, Gomez-Galdon M, Chintinne M, Sirtaine N, de St Aubain N, Laios I, Roy F, Larsimont D. Tumor Banks: A Quality Control Scheme Proposal. Front Med (Lausanne). 2019 Oct 17;6:225. doi: 10.3389/fmed.2019.00225. eCollection 2019. PMID: 31681781; PMCID: PMC6811598.
Copy Download .nbib Format: NLM
Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients.

NPJ breast cancer

Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, De Schepper M, Geukens T, Lucidi V, Ignatiadis M, Aftimos P, Sotiriou C, Piccart M, Hendlisz A, Van Laere S, Dirix L, Noël JC, Biganzoli E, Larsimont D, Desmedt C, Donckier V.
PMID: 33339824
NPJ Breast Cancer. 2020 Dec 18;6(1):64. doi: 10.1038/s41523-020-00209-1.

Currently, there are no markers to identify patients with liver-only or liver-dominant metastases that would benefit from hepatic surgery. Here we characterized histopathological growth patterns (HGPs) of liver metastases in a consecutive series of 36 breast cancer patients who...

Cite
Bohlok A, Vermeulen P, Leduc S, et al. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients. NPJ Breast Cancer. 2020;6(1):64doi: 10.1038/s41523-020-00209-1.
Bohlok, A., Vermeulen, P., Leduc, S., Latacz, E., Botzenhart, L., Richard, F., De Schepper, M., Geukens, T., Lucidi, V., Ignatiadis, M., Aftimos, P., Sotiriou, C., Piccart, M., Hendlisz, A., Van Laere, S., Dirix, L., Noël, J. C., Biganzoli, E., Larsimont, D., Desmedt, C., & Donckier, V. (2020). Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients. NPJ breast cancer, 6(1), 64. https://doi.org/10.1038/s41523-020-00209-1
Bohlok, Ali, et al. "Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients." NPJ breast cancer vol. 6,1 (2020): 64. doi: https://doi.org/10.1038/s41523-020-00209-1
Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, De Schepper M, Geukens T, Lucidi V, Ignatiadis M, Aftimos P, Sotiriou C, Piccart M, Hendlisz A, Van Laere S, Dirix L, Noël JC, Biganzoli E, Larsimont D, Desmedt C, Donckier V. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients. NPJ Breast Cancer. 2020 Dec 18;6(1):64. doi: 10.1038/s41523-020-00209-1. PMID: 33339824; PMCID: PMC7749172.
Copy Download .nbib Format: NLM
Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.

Frontiers in immunology

Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Risso P, Rodrigues Vitória J, Richard F, Migliori E, Noël G, Duvillier H, Craciun L, Veys I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K.
PMID: 29163490
Front Immunol. 2017 Oct 30;8:1412. doi: 10.3389/fimmu.2017.01412. eCollection 2017.

There is an exponentially growing interest in targeting immune checkpoint molecules in breast cancer (BC), particularly in the triple-negative subtype where unmet treatment needs remain. This study was designed to analyze the expression, localization, and prognostic role of PD-1,...

Cite
Solinas C, Garaud S, De Silva P, et al. Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. Front Immunol. 2017;8:1412doi: 10.3389/fimmu.2017.01412.
Solinas, C., Garaud, S., De Silva, P., Boisson, A., Van den Eynden, G., de Wind, A., Risso, P., Rodrigues Vitória, J., Richard, F., Migliori, E., Noël, G., Duvillier, H., Craciun, L., Veys, I., Awada, A., Detours, V., Larsimont, D., Piccart-Gebhart, M., & Willard-Gallo, K. (2017). Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. Frontiers in immunology, 81412. https://doi.org/10.3389/fimmu.2017.01412
Solinas, Cinzia, et al. "Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer." Frontiers in immunology vol. 8 (2017): 1412. doi: https://doi.org/10.3389/fimmu.2017.01412
Solinas C, Garaud S, De Silva P, Boisson A, Van den Eynden G, de Wind A, Risso P, Rodrigues Vitória J, Richard F, Migliori E, Noël G, Duvillier H, Craciun L, Veys I, Awada A, Detours V, Larsimont D, Piccart-Gebhart M, Willard-Gallo K. Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer. Front Immunol. 2017 Oct 30;8:1412. doi: 10.3389/fimmu.2017.01412. eCollection 2017. PMID: 29163490; PMCID: PMC5670348.
Copy Download .nbib Format: NLM
Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients.

Genomics data

Haibe-Kains B, Desmedt C, Di Leo A, Azambuja E, Larsimont D, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L, D'Hondt V, Piccart-Gebhart M, Sotiriou C.
PMID: 26484051
Genom Data. 2013 Oct 01;1:7-10. doi: 10.1016/j.gdata.2013.09.001. eCollection 2013 Dec.

Validated biomarkers predictive of response/resistance to anthracyclines in breast cancer are currently lacking. The neoadjuvant Trial of Principle (TOP) study, in which patients with estrogen receptor (ER)-negative tumors were treated with anthracycline (epirubicin) monotherapy, was specifically designed to evaluate...

Cite
Haibe-Kains B, Desmedt C, Di Leo A, et al. Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients. Genom Data. 2013;1:7-10doi: 10.1016/j.gdata.2013.09.001.
Haibe-Kains, B., Desmedt, C., Di Leo, A., Azambuja, E., Larsimont, D., Selleslags, J., Delaloge, S., Duhem, C., Kains, J. P., Carly, B., Maerevoet, M., Vindevoghel, A., Rouas, G., Lallemand, F., Durbecq, V., Cardoso, F., Salgado, R., Rovere, R., Bontempi, G., Michiels, S., Buyse, M., Nogaret, J. M., Qi, Y., Symmans, F., Pusztai, L., D'Hondt, V., Piccart-Gebhart, M., & Sotiriou, C. (2013). Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients. Genomics data, 17-10. https://doi.org/10.1016/j.gdata.2013.09.001
Haibe-Kains, B, et al. "Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients." Genomics data vol. 1 (2013): 7-10. doi: https://doi.org/10.1016/j.gdata.2013.09.001
Haibe-Kains B, Desmedt C, Di Leo A, Azambuja E, Larsimont D, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L, D'Hondt V, Piccart-Gebhart M, Sotiriou C. Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients. Genom Data. 2013 Oct 01;1:7-10. doi: 10.1016/j.gdata.2013.09.001. eCollection 2013 Dec. PMID: 26484051; PMCID: PMC4608867.
Copy Download .nbib Format: NLM
Pathology as the cornerstone of human tissue banking: European consensus expert group report.

Biopreservation and biobanking

Hainaut P, Caboux E, Bevilacqua G, Bosman F, Dassesse T, Hoefler H, Janin A, Langer R, Larsimont D, Morente M, Riegman P, Schirmacher P, Stanta G, Zatloukal K.
PMID: 24835883
Biopreserv Biobank. 2009 Sep;7(3):157-60. doi: 10.1089/bio.2010.7303.

Aside from ethical considerations, the primary requirement for usage of human tissues in basic or translational research is the thorough characterization of tissues. The second, but equally essential, requirement is that tissues be collected, processed, annotated, and preserved in...

Cite
Hainaut P, Caboux E, Bevilacqua G, et al. Pathology as the cornerstone of human tissue banking: European consensus expert group report. Biopreserv Biobank. 2009;7(3):157-60doi: 10.1089/bio.2010.7303.
Hainaut, P., Caboux, E., Bevilacqua, G., Bosman, F., Dassesse, T., Hoefler, H., Janin, A., Langer, R., Larsimont, D., Morente, M., Riegman, P., Schirmacher, P., Stanta, G., & Zatloukal, K. (2009). Pathology as the cornerstone of human tissue banking: European consensus expert group report. Biopreservation and biobanking, 7(3), 157-60. https://doi.org/10.1089/bio.2010.7303
Hainaut, Pierre, et al. "Pathology as the cornerstone of human tissue banking: European consensus expert group report." Biopreservation and biobanking vol. 7,3 (2009): 157-60. doi: https://doi.org/10.1089/bio.2010.7303
Hainaut P, Caboux E, Bevilacqua G, Bosman F, Dassesse T, Hoefler H, Janin A, Langer R, Larsimont D, Morente M, Riegman P, Schirmacher P, Stanta G, Zatloukal K. Pathology as the cornerstone of human tissue banking: European consensus expert group report. Biopreserv Biobank. 2009 Sep;7(3):157-60. doi: 10.1089/bio.2010.7303. PMID: 24835883.
Copy Download .nbib Format: NLM
N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by .

Oncotarget

Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Larsimont D, Doumont G, Van Simaeys G, Goldman S, Flamen P, Ghanem G.
PMID: 28915583
Oncotarget. 2017 Apr 10;8(34):56185-56198. doi: 10.18632/oncotarget.17015. eCollection 2017 Aug 22.

Trastuzumab remains an important drug in the management of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer (BC). Several studies reported resistance mechanisms to trastuzumab, including impaired HER2-accessibility caused by mucin 4 (MUC4). Previously, we demonstrated an...

Cite
Wimana Z, Gebhart G, Guiot T, et al. N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by . Oncotarget. 2017;8(34):56185-56198doi: 10.18632/oncotarget.17015.
Wimana, Z., Gebhart, G., Guiot, T., Vanderlinden, B., Larsimont, D., Doumont, G., Van Simaeys, G., Goldman, S., Flamen, P., & Ghanem, G. (2017). N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by . Oncotarget, 8(34), 56185-56198. https://doi.org/10.18632/oncotarget.17015
Wimana, Zéna, et al. "N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by ." Oncotarget vol. 8,34 (2017): 56185-56198. doi: https://doi.org/10.18632/oncotarget.17015
Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Larsimont D, Doumont G, Van Simaeys G, Goldman S, Flamen P, Ghanem G. N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by . Oncotarget. 2017 Apr 10;8(34):56185-56198. doi: 10.18632/oncotarget.17015. eCollection 2017 Aug 22. PMID: 28915583; PMCID: PMC5593554.
Copy Download .nbib Format: NLM
Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Richard F, Majjaj S, Venet D, Rothé F, Pingitore J, Boeckx B, Marchio C, Clatot F, Bertucci F, Mariani O, Galant C, Eynden GVD, Salgado R, Biganzoli E, Lambrechts D, Vincent-Salomon A, Pruneri G, Larsimont D, Sotiriou C, Desmedt C.
PMID: 32943456
Clin Cancer Res. 2020 Dec 01;26(23):6254-6265. doi: 10.1158/1078-0432.CCR-20-2268. Epub 2020 Sep 17.

PURPOSE: Invasive lobular carcinoma (ILC) represents the second most common histologic breast cancer subtype after invasive ductal carcinoma (IDC). While primary ILC has been extensively studied, metastatic ILC has been poorly characterized at the genomic and immune level.EXPERIMENTAL DESIGN:...

Cite
Richard F, Majjaj S, Venet D, et al. Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clin Cancer Res. 2020;26(23):6254-6265doi: 10.1158/1078-0432.CCR-20-2268.
Richard, F., Majjaj, S., Venet, D., Rothé, F., Pingitore, J., Boeckx, B., Marchio, C., Clatot, F., Bertucci, F., Mariani, O., Galant, C., Eynden, G. V. D., Salgado, R., Biganzoli, E., Lambrechts, D., Vincent-Salomon, A., Pruneri, G., Larsimont, D., Sotiriou, C., & Desmedt, C. (2020). Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(23), 6254-6265. https://doi.org/10.1158/1078-0432.CCR-20-2268
Richard, François, et al. "Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26,23 (2020): 6254-6265. doi: https://doi.org/10.1158/1078-0432.CCR-20-2268
Richard F, Majjaj S, Venet D, Rothé F, Pingitore J, Boeckx B, Marchio C, Clatot F, Bertucci F, Mariani O, Galant C, Eynden GVD, Salgado R, Biganzoli E, Lambrechts D, Vincent-Salomon A, Pruneri G, Larsimont D, Sotiriou C, Desmedt C. Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clin Cancer Res. 2020 Dec 01;26(23):6254-6265. doi: 10.1158/1078-0432.CCR-20-2268. Epub 2020 Sep 17. PMID: 32943456.
Copy Download .nbib Format: NLM
Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment.

Frontiers in molecular biosciences

Boisson A, Noël G, Saiselet M, Rodrigues-Vitória J, Thomas N, Fontsa ML, Sofronii D, Naveaux C, Duvillier H, Craciun L, Larsimont D, Awada A, Detours V, Willard-Gallo K, Garaud S.
PMID: 34621785
Front Mol Biosci. 2021 Sep 21;8:673042. doi: 10.3389/fmolb.2021.673042. eCollection 2021.

Our expanding knowledge of the interactions between tumor cells and their microenvironment has helped to revolutionize cancer treatments, including the more recent development of immunotherapies. Immune cells are an important component of the tumor microenvironment that influence progression and...

Cite
Boisson A, Noël G, Saiselet M, et al. Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment. Front Mol Biosci. 2021;8:673042doi: 10.3389/fmolb.2021.673042.
Boisson, A., Noël, G., Saiselet, M., Rodrigues-Vitória, J., Thomas, N., Fontsa, M. L., Sofronii, D., Naveaux, C., Duvillier, H., Craciun, L., Larsimont, D., Awada, A., Detours, V., Willard-Gallo, K., & Garaud, S. (2021). Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment. Frontiers in molecular biosciences, 8673042. https://doi.org/10.3389/fmolb.2021.673042
Boisson, Anaïs, et al. "Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment." Frontiers in molecular biosciences vol. 8 (2021): 673042. doi: https://doi.org/10.3389/fmolb.2021.673042
Boisson A, Noël G, Saiselet M, Rodrigues-Vitória J, Thomas N, Fontsa ML, Sofronii D, Naveaux C, Duvillier H, Craciun L, Larsimont D, Awada A, Detours V, Willard-Gallo K, Garaud S. Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment. Front Mol Biosci. 2021 Sep 21;8:673042. doi: 10.3389/fmolb.2021.673042. eCollection 2021. PMID: 34621785; PMCID: PMC8490683.
Copy Download .nbib Format: NLM
Systemic Sentinel Lymph Node Detection Using Fluorescence Imaging After Indocyanine Green Intravenous Injection in Colorectal Cancer: Protocol for a Feasibility Study.

JMIR research protocols

Liberale G, Vankerckhove S, Bouazza F, Gomez Galdon M, Larsimont D, Moreau M, Bourgeois P, Donckier V.
PMID: 32554370
JMIR Res Protoc. 2020 Aug 14;9(8):e17976. doi: 10.2196/17976.

BACKGROUND: Nodal staging is a major concern in colorectal cancer as it is an important prognostic factor. Several techniques that could potentially improve patient treatment and prognosis have been developed to increase the accuracy of nodal staging. Sentinel lymph...

Cite
Liberale G, Vankerckhove S, Bouazza F, et al. Systemic Sentinel Lymph Node Detection Using Fluorescence Imaging After Indocyanine Green Intravenous Injection in Colorectal Cancer: Protocol for a Feasibility Study. JMIR Res Protoc. 2020;9(8):e17976doi: 10.2196/17976.
Liberale, G., Vankerckhove, S., Bouazza, F., Gomez Galdon, M., Larsimont, D., Moreau, M., Bourgeois, P., & Donckier, V. (2020). Systemic Sentinel Lymph Node Detection Using Fluorescence Imaging After Indocyanine Green Intravenous Injection in Colorectal Cancer: Protocol for a Feasibility Study. JMIR research protocols, 9(8), e17976. https://doi.org/10.2196/17976
Liberale, Gabriel, et al. "Systemic Sentinel Lymph Node Detection Using Fluorescence Imaging After Indocyanine Green Intravenous Injection in Colorectal Cancer: Protocol for a Feasibility Study." JMIR research protocols vol. 9,8 (2020): e17976. doi: https://doi.org/10.2196/17976
Liberale G, Vankerckhove S, Bouazza F, Gomez Galdon M, Larsimont D, Moreau M, Bourgeois P, Donckier V. Systemic Sentinel Lymph Node Detection Using Fluorescence Imaging After Indocyanine Green Intravenous Injection in Colorectal Cancer: Protocol for a Feasibility Study. JMIR Res Protoc. 2020 Aug 14;9(8):e17976. doi: 10.2196/17976. PMID: 32554370; PMCID: PMC7455862.
Copy Download .nbib Format: NLM
Comparison of immunohistochemical and biochemical measurement of steroid receptors in breast cancer: are both still necessary?.

Breast (Edinburgh, Scotland)

Gotlieb L, Kaufman L, Leclercq G, Nogaret JM, Buggenhout A, Larsimont D.
PMID: 14965626
Breast. 2001 Dec;10(6):470-5. doi: 10.1054/brst.2000.0283.

In our institute, the oestrogen and progesterone receptors of breast cancer samples are analyzed by biochemistry and immunohistochemistry. The purpose of this study is to evaluate and compare both techniques and establish whether one of them should be used...

Cite
Gotlieb L, Kaufman L, Leclercq G, et al. Comparison of immunohistochemical and biochemical measurement of steroid receptors in breast cancer: are both still necessary?. Breast. 2001;10(6):470-5doi: 10.1054/brst.2000.0283.
Gotlieb, L., Kaufman, L., Leclercq, G., Nogaret, J. M., Buggenhout, A., & Larsimont, D. (2001). Comparison of immunohistochemical and biochemical measurement of steroid receptors in breast cancer: are both still necessary?. Breast (Edinburgh, Scotland), 10(6), 470-5. https://doi.org/10.1054/brst.2000.0283
Gotlieb, L, et al. "Comparison of immunohistochemical and biochemical measurement of steroid receptors in breast cancer: are both still necessary?." Breast (Edinburgh, Scotland) vol. 10,6 (2001): 470-5. doi: https://doi.org/10.1054/brst.2000.0283
Gotlieb L, Kaufman L, Leclercq G, Nogaret JM, Buggenhout A, Larsimont D. Comparison of immunohistochemical and biochemical measurement of steroid receptors in breast cancer: are both still necessary?. Breast. 2001 Dec;10(6):470-5. doi: 10.1054/brst.2000.0283. PMID: 14965626.
Copy Download .nbib Format: NLM
Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute.

International journal of breast cancer

Philippson C, Simon S, Vandekerkhove C, Hertens D, Veys I, Noterman D, De Neubourg F, Larsimont D, Bourgeois P, Van Houtte P, Nogaret JM.
PMID: 25009747
Int J Breast Cancer. 2014;2014:627352. doi: 10.1155/2014/627352. Epub 2014 Jun 09.

Objectives. The aim of this prospective phase II study is to evaluate the treatment of early-stage breast cancer (T1 N0) with intraoperative electron radiation therapy (IOERT) in terms of local control, early complications, and cosmesis. Patients and Methods. From...

Cite
Philippson C, Simon S, Vandekerkhove C, et al. Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute. Int J Breast Cancer. 2014;2014:627352doi: 10.1155/2014/627352.
Philippson, C., Simon, S., Vandekerkhove, C., Hertens, D., Veys, I., Noterman, D., De Neubourg, F., Larsimont, D., Bourgeois, P., Van Houtte, P., & Nogaret, J. M. (2014). Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute. International journal of breast cancer, 2014627352. https://doi.org/10.1155/2014/627352
Philippson, C, et al. "Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute." International journal of breast cancer vol. 2014 (2014): 627352. doi: https://doi.org/10.1155/2014/627352
Philippson C, Simon S, Vandekerkhove C, Hertens D, Veys I, Noterman D, De Neubourg F, Larsimont D, Bourgeois P, Van Houtte P, Nogaret JM. Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute. Int J Breast Cancer. 2014;2014:627352. doi: 10.1155/2014/627352. Epub 2014 Jun 09. PMID: 25009747; PMCID: PMC4070416.
Copy Download .nbib Format: NLM
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.

Oncoimmunology

Buisseret L, Garaud S, de Wind A, Van den Eynden G, Boisson A, Solinas C, Gu-Trantien C, Naveaux C, Lodewyckx JN, Duvillier H, Craciun L, Veys I, Larsimont D, Piccart-Gebhart M, Stagg J, Sotiriou C, Willard-Gallo K.
PMID: 28197375
Oncoimmunology. 2016 Dec 14;6(1):e1257452. doi: 10.1080/2162402X.2016.1257452. eCollection 2017.

The clinical relevance of tumor-infiltrating lymphocytes (TIL) in breast cancer (BC) has been clearly established by their demonstrated correlation with long-term positive outcomes. Nevertheless, the relationship between protective immunity, observed in some patients, and critical features of the infiltrate...

Cite
Buisseret L, Garaud S, de Wind A, et al. Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer. Oncoimmunology. 2016;6(1):e1257452doi: 10.1080/2162402X.2016.1257452.
Buisseret, L., Garaud, S., de Wind, A., Van den Eynden, G., Boisson, A., Solinas, C., Gu-Trantien, C., Naveaux, C., Lodewyckx, J. N., Duvillier, H., Craciun, L., Veys, I., Larsimont, D., Piccart-Gebhart, M., Stagg, J., Sotiriou, C., & Willard-Gallo, K. (2017). Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer. Oncoimmunology, 6(1), e1257452. https://doi.org/10.1080/2162402X.2016.1257452
Buisseret, Laurence, et al. "Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer." Oncoimmunology vol. 6,1 (2017): e1257452. doi: https://doi.org/10.1080/2162402X.2016.1257452
Buisseret L, Garaud S, de Wind A, Van den Eynden G, Boisson A, Solinas C, Gu-Trantien C, Naveaux C, Lodewyckx JN, Duvillier H, Craciun L, Veys I, Larsimont D, Piccart-Gebhart M, Stagg J, Sotiriou C, Willard-Gallo K. Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer. Oncoimmunology. 2016 Dec 14;6(1):e1257452. doi: 10.1080/2162402X.2016.1257452. eCollection 2017. PMID: 28197375; PMCID: PMC5283629.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 18 entries